SLC25A51 pseudogene 1 (SLC25A51P1)

SLC25A51 pseudogene 1 (SLC25A51P1, bA707M13.1) appears to be a \"pseudogene\" and not a functional protein-coding gene, transporter, or canonical therapeutic target. It should not be confused with \"SLC25A51\", which is a protein-coding gene encoding the mammalian mitochondrial \"NAD+ transporter\" and is an active molecule involved in NAD+ import into the mitochondrial matrix—a process essential for mitochondrial respiration and metabolism[1][3][5]. Being a pseudogene, SLC25A51P1 does not encode a functional protein and does not have known biological functions, disease associations, therapeutic roles, or drug interactions relevant to clinical or research targeting. There is therefore something wrong with suggesting SLC25A51P1 as a therapeutic target.\n\nCritical Notes:\n\n- The canonical \"therapeutic target\" would be \"SLC25A51\", not SLC25A51P1[1][3][5].\n- Pseudogenes like SLC25A51P1 are typically non-functional genomic sequences and, unless evidence exists for regulatory or noncoding RNA activity, are not assigned roles in drug development or direct cell biology[2].\n- No aliases for SLC25A51P1 are widely reported beyond those listed above. SLC25A51 is part of the mitochondrial carrier family but SLC25A51P1, as a pseudogene, is not classified in transporter or any active target classes[2][3].\n\nIf you intended to ask about \"SLC25A51\" itself (the mitochondrial NAD+ transporter), please clarify, as this is a functionally active and biomedically relevant target[1][3][5]. For the pseudogene SLC25A51P1, the information above reflects its status and lack of target relevance.

Other names

SLC25A51P1bA707M13.1